These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2125000)

  • 41. Treatment of ECL cell carcinoids with octreotide LAR.
    Fykse V; Sandvik AK; Qvigstad G; Falkmer SE; Syversen U; Waldum HL
    Scand J Gastroenterol; 2004 Jul; 39(7):621-8. PubMed ID: 15370681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histamine metabolism of gastric carcinoids in Mastomys natalensis.
    Kölby L; Wängberg B; Ahlman H; Modlin IM; Nilsson O
    Yale J Biol Med; 1998; 71(3-4):207-15. PubMed ID: 10461353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
    Konagaya T; Bernsand M; Norlén P; Håkanson R
    Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
    Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
    Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffuse enterochromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: a complication of pernicious anaemia.
    Hodges JR; Isaacson P; Wright R
    Gut; 1981 Mar; 22(3):237-41. PubMed ID: 7227860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomised trial of the effect of a gastrin/CCK
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ECL cells: biology and pathobiology.
    Håkanson R; Chen D; Tielemans Y; Andersson K; Ryberg B; Sundler F; Mattsson H
    Digestion; 1994; 55 Suppl 3():38-45. PubMed ID: 7698536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia.
    Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A; Thompson DG; Dockray GJ
    Gastroenterology; 1999 Jun; 116(6):1310-8. PubMed ID: 10348814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrin is the most important factor in ECL tumorigenesis.
    Waldum HL; Sandvik AK; Idle JR
    Gastroenterology; 1998 May; 114(5):1113-5. PubMed ID: 9606099
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathophysiological effects of long-term acid suppression in man.
    McCloy RF; Arnold R; Bardhan KD; Cattan D; Klinkenberg-Knol E; Maton PN; Riddell RH; Sipponen P; Walan A
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):96S-120S. PubMed ID: 7859587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omeprazole: long-term safety.
    Arnold R; Koop H
    Digestion; 1989; 44 Suppl 1():77-86. PubMed ID: 2691313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of omeprazole-induced hypergastrinemia on the oxyntic mucosa of mastomys.
    Brenna E; Håkanson R; Sundler F; Sandvik AK; Waldum HL
    Scand J Gastroenterol; 1991 Jun; 26(6):667-72. PubMed ID: 1862305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines.
    Håkanson R; Blom H; Carlsson E; Larsson H; Ryberg B; Sundler F
    Regul Pept; 1986 Feb; 13(3-4):225-33. PubMed ID: 3704196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy.
    Hirschowitz BI; Griffith J; Pellegrin D; Cummings OW
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1409-18. PubMed ID: 1551550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypergastrinemia after blockade of acid secretion in the rat: trophic effects.
    Sundler F; Håkanson R; Carlsson E; Larsson H; Mattsson H
    Digestion; 1986; 35 Suppl 1():56-69. PubMed ID: 3792672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of gastric resection in the management of multicentric argyrophil gastric carcinoids.
    Wängberg B; Grimelius L; Granérus G; Conradi N; Jansson S; Ahlman H
    Surgery; 1990 Nov; 108(5):851-7. PubMed ID: 2237765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric carcinoids and related endocrine growths.
    Solcia E; Capella C; Sessa F; Rindi G; Cornaggia M; Riva C; Villani L
    Digestion; 1986; 35 Suppl 1():3-22. PubMed ID: 3539679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.
    Nilsson O; Wängberg B; Johansson L; Modlin IM; Ahlman H
    Yale J Biol Med; 1992; 65(6):741-51; discussion 827-9. PubMed ID: 1341076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.